Core Viewpoint - Semler Scientific, Inc. is facing a securities fraud class action lawsuit due to alleged misleading statements regarding a Department of Justice investigation into the company's reimbursement claims related to the QuantaFlo device [3][5]. Group 1: Company Background and Events - On February 28, 2025, Semler disclosed in its Form 10-K that it received a civil investigative demand from the DOJ in July 2017 concerning its reimbursement claims [3]. - Following unsuccessful settlement discussions with the DOJ in February 2025, Semler's share price fell by approximately 9.39%, from $42.92 to $38.89 [3]. - On April 15, 2025, Semler announced a settlement agreement of $29.75 million to resolve all claims, leading to a further decline in share price by about 9.9%, from $34.40 to $31.00 [4]. Group 2: Lawsuit Details - The class action lawsuit is on behalf of investors who purchased Semler securities from March 10, 2021, to April 15, 2025, alleging that the company made false or misleading statements regarding the DOJ investigation [5]. - The lawsuit claims that the company failed to disclose material information about the investigation, which resulted in investor damages when the truth was revealed [5].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Semler Scientific, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline for a securities class action lawsuit [1][5]. Group 1: Class Action Details - The Class Period for the Semler Scientific securities is from March 10, 2021, to April 15, 2025 [1]. - Investors who purchased securities during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by October 28, 2025 [3]. Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [4]. - The Rosen Law Firm has a history of successful settlements, including the largest securities class action settlement against a Chinese company at the time, and has recovered hundreds of millions of dollars for investors [4]. Group 3: Case Allegations - The lawsuit alleges that Semler Scientific made materially false and misleading statements and failed to disclose a significant investigation by the U.S. Department of Justice regarding violations of the False Claims Act [5]. - The lawsuit claims that these misleading statements resulted in investor damages when the true details became public [5].

Core Viewpoint - A class action securities lawsuit has been filed against Semler Scientific, Inc. for alleged securities fraud affecting investors between March 10, 2021, and April 15, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Semler Scientific failed to disclose a significant investigation by the U.S. Department of Justice regarding violations of the False Claims Act, while discussing potential violations in hypothetical terms [2]. - As a result of these actions, the public statements made by the defendants were materially false and misleading throughout the relevant period [2]. Group 2: Next Steps for Investors - Investors who experienced losses in Semler Scientific during the specified timeframe have until October 28, 2025, to request to be appointed as lead plaintiff [3]. - Participation in the lawsuit does not require serving as a lead plaintiff, and class members may be entitled to compensation without any out-of-pocket costs [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and has been recognized as one of the top securities litigation firms in the U.S. for seven consecutive years [4].

Core Viewpoint - A class action securities lawsuit has been filed against Semler Scientific, Inc. for alleged securities fraud affecting investors between March 10, 2021, and April 15, 2025 [2][3]. Group 1: Lawsuit Details - The lawsuit claims that Semler Scientific failed to disclose a significant investigation by the U.S. Department of Justice regarding violations of the False Claims Act, while discussing potential violations in hypothetical terms [3]. - The complaint alleges that the public statements made by the defendants were materially false and misleading during the relevant time period [3]. Group 2: Investor Information - Investors who suffered losses in Semler Scientific during the specified timeframe have until October 28, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [4]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, and there is no obligation to participate [4]. Group 3: Legal Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and has been recognized as one of the top securities litigation firms in the U.S. for seven consecutive years [5].

Core Viewpoint - A class action lawsuit has been filed against Semler Scientific, Inc. for failing to disclose a material investigation by the U.S. Department of Justice regarding potential violations of the False Claims Act [2][3]. Group 1: Allegations and Investigations - The lawsuit alleges that Semler Scientific did not disclose an investigation by the DOJ into possible violations of the False Claims Act during the class period from March 10, 2021, to April 15, 2025 [2]. - On February 28, 2025, Semler Scientific revealed it had received an initial civil investigative demand from the DOJ in July 2017, concerning the marketing of tests using photoplethysmography technology as reimbursable by Medicare [3]. - Following unsuccessful settlement discussions with the DOJ on February 11, 2025, there was a risk of a civil lawsuit being filed, which led to a stock price drop of $4.03, or 9.38%, closing at $38.89 on March 3, 2025 [3]. Group 2: Settlement and Financial Impact - On April 15, 2025, Semler Scientific reported to the SEC that it had reached a settlement agreement with the DOJ for $29.75 million, excluding attorney fees, but noted that further payments might be necessary and the risk of a DOJ lawsuit still exists [4]. - Following the announcement of the settlement, Semler Scientific's stock fell by $3.40 per share, or 9.88%, closing at $31.00 on April 16, 2025 [4]. Group 3: Class Action Participation - Shareholders interested in participating in the class action must submit their paperwork by October 28, 2025, to serve as lead plaintiff, representing other class members [5]. - Shareholders do not need to participate in the case to be eligible for recovery and can remain absent class members if they choose [5].

Core Viewpoint - Semler Scientific, Inc. is facing a class action lawsuit due to allegations of issuing materially false and misleading statements regarding a Department of Justice investigation into violations of the False Claims Act during the class period from March 10, 2021, to April 15, 2025 [3][4]. Group 1 - The class action lawsuit is based on allegations that Semler Scientific failed to disclose a material investigation by the United States Department of Justice, which is related to potential violations of the False Claims Act [3]. - The lawsuit claims that the defendants' public statements were materially false and misleading throughout the relevant time period [3]. - Shareholders who purchased shares of Semler Scientific during the specified class period are encouraged to register for participation in the class action [4]. Group 2 - The deadline for shareholders to seek lead plaintiff status in the class action is October 28, 2025 [4]. - Once registered, shareholders will be enrolled in a portfolio monitoring software to receive updates on the case [4]. - The Gross Law Firm, which is handling the case, is a nationally recognized class action law firm dedicated to protecting investors' rights [5].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Semler Scientific, Inc. regarding a class action lawsuit due to alleged misleading statements and failure to disclose a material investigation by the U.S. Department of Justice [1][2]. Group 1: Class Action Details - The class period for the lawsuit is from March 10, 2021, to April 15, 2025 [2]. - Allegations include that Semler Scientific did not disclose a material investigation by the U.S. Department of Justice related to violations of the False Claims Act, leading to materially false and misleading public statements [2]. - The deadline for shareholders to register for the class action is October 28, 2025, and there is no cost or obligation to participate [3]. Group 2: Firm's Mission and Commitment - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors who have suffered due to deceit, fraud, and illegal business practices [4]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who incurred losses from false or misleading statements that inflated stock prices [4].

Core Points - A class action securities lawsuit has been filed against Semler Scientific, Inc. for alleged securities fraud affecting investors between March 10, 2021, and April 15, 2025 [2][3] - The lawsuit claims that Semler Scientific failed to disclose a significant investigation by the U.S. Department of Justice regarding violations of the False Claims Act, leading to materially false and misleading public statements [3] Class Definition - The lawsuit aims to recover losses for investors adversely affected by the alleged fraud during the specified time frame [2] Case Details - The complaint alleges two main points: 1. Semler Scientific did not disclose a material investigation by the U.S. Department of Justice [3] 2. Public statements made by the defendants were materially false and misleading [3] Next Steps - Investors who suffered losses during the relevant period have until October 28, 2025, to request to be appointed as lead plaintiff [4] - Participation in the lawsuit does not require serving as a lead plaintiff, and there are no out-of-pocket costs for class members [4] Why Levi & Korsinsky - The firm has a strong track record, having secured hundreds of millions of dollars for shareholders and being recognized as one of the top securities litigation firms in the U.S. for seven consecutive years [5]

Core Viewpoint - Semler Scientific, Inc. is facing a class action lawsuit due to allegations of issuing materially false and misleading statements regarding a material investigation by the U.S. Department of Justice related to the False Claims Act [2][4]. Group 1: Allegations and Class Period - The class period for the lawsuit is defined as March 10, 2021, to April 15, 2025 [2]. - Allegations include failure to disclose a material investigation by the U.S. Department of Justice and discussing potential violations of the False Claims Act in hypothetical terms [2]. Group 2: Next Steps for Shareholders - Shareholders who purchased shares during the specified class period are encouraged to register for the class action, with a deadline of October 28, 2025, to seek lead plaintiff status [3]. - Registered shareholders will be enrolled in a portfolio monitoring software to receive updates on the case [3]. Group 3: Law Firm's Commitment - The Gross Law Firm aims to protect investors' rights and ensure companies adhere to responsible business practices [4]. - The firm seeks recovery for investors who suffered losses due to false or misleading statements that led to artificial inflation of the company's stock [4].

NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Semler Scientific, Inc. (NASDAQ: SMLR). Shareholders who purchased shares of SMLR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/semler-scientific-inc-loss-submission-form/?id=166133&from=3 CLASS PERIOD ...